\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ currently\\ followed\\ by\\ rheumatology\\.\ \(0\)\
\-\ feet\\:\\ \\ the\\ fifth\\ pip\\/dip\\ demonstrate\\ erosion\\ with\\ pencil\\ in\\ cup\\ deformity\\.\\ \\ marginal\\ erosions\\ of\\ the\\ lateral\\ fifth\\ metatarsal\\ is\\ present\\ with\\ sclerotic\\ margin\\.\ \(0\)\
\-\ hands\\:\\ \\ loss\\ of\\ joint\\ space\\ of\\ the\\ dip\\ joints\\ of\\ the\\ left\\ second\\,\\ third\\,\\ fourth\\ and\\ fifth\\ digits\\ and\\ right\\ dip\\ joints\\ with\\ prolific\\ bone\\ formation\\.\\ \\ erosions\\ of\\ the\\ mcp\\ joints\\ are\\ present\\.\\ \\ ankylosis\\ of\\ the\\ left\\ first\\ dip\\ and\\ partial\\ ankylosis\\ of\\ the\\ right\\ first\\ dip\\ joint\\.\ \(0\)\
\-\ psoriatic\\ arthritis\ \(11\)\
\-\ erosive\\ osteoarthritis\ \(8\)\
\-\ psoriatic\\ arthritis\ \(11\)\
\-\ history\\ of\\ psoriasis\\.\ \(1\)\
\-\ psoriasis\\ is\\ a\\ chronic\\,\\ inflammatory\\,\\ proliferative\\ disease\\ of\\ the\\ skin\\.\\ \\ psoriatic\\ arthritis\\ occurs\\ in\\ 5\\-8\\ percent\\ of\\ patients\\ with\\ psoriasis\\.\\ \\ the\\ mean\\ age\\ of\\ diagnosis\\ is\\ 40\\ years\\ and\\ ranges\\ from\\ 20\\ to\\ 39\\ years\\ in\\ men\\ and\\ 40\\ to\\ 59\\ years\\ in\\ women\\.\\ \\ bone\\ erosion\\ and\\ proliferation\\ can\\ strongly\\ suggest\\ the\\ diagnosis\\.\\ \\ erosions\\ begin\\ in\\ the\\ joint\\ margins\\ and\\ extend\\ along\\ the\\ articular\\ surface\\ or\\ progress\\ away\\ from\\ the\\ joint\\.\\ \\ severe\\ erosions\\ may\\ widen\\ the\\ joint\\ space\\ and\\ lead\\ to\\ a\\ pencil\\ in\\ cup\\ or\\ cup\\ and\\ saucer\\ appearance\\.\\ \\ asymmetric\\ dip\\ or\\ ip\\ joint\\ involvement\\ and\\ involvement\\ of\\ a\\ few\\ rays\\ are\\ characteristic\\.\\ \\ \ \(0\)\
\-\ bennett\\,\\ dl\\,\\ ohashi\\,\\ k\\,\\ and\\ el\\-khoury\\,\\ gy\\ \\"spondyloarthropathies\\:\\ ankylosing\\ spondylitis\\ and\\ psoriatic\\ \\ arthritis\\"\\.\\ \\ radiologic\\ clinics\\ of\\ north\\ america\\.\\ \\ 42\\ \\(2004\\)\\ 121\\-134\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ dip\\:\\ 0\\.11687292609130347\ \(0\)\
\-\ cup\\:\\ 0\\.09171881559069886\ \(0\)\
\-\ psoriatic\\:\\ 0\\.08480587288620334\ \(0\)\
\-\ erosions\\:\\ 0\\.07799145646190583\ \(0\)\
\-\ psoriasis\\:\\ 0\\.0754008422575838\ \(0\)\
\-\ joint\\:\\ 0\\.06823282111215015\ \(0\)\
\-\ pencil\\:\\ 0\\.06351363074319662\ \(0\)\
\-\ arthritis\\:\\ 0\\.060094361317579996\ \(0\)\
\-\ fifth\\:\\ 0\\.05788128443112847\ \(0\)\
\-\ joints\\:\\ 0\\.04827461290775393\ \(0\)\
\-\ ankylosis\\:\\ 0\\.04789947448899183\ \(0\)\
\-\ pip\\/dip\\:\\ 0\\.03627785359656995\ \(0\)\
\-\ prolific\\:\\ 0\\.03627785359656995\ \(0\)\
\-\ ohashi\\:\\ 0\\.03627785359656995\ \(0\)\
\-\ 121\\-134\\:\\ 0\\.03627785359656995\ \(0\)\
\-\ erosion\\:\\ 0\\.03552023665544225\ \(0\)\
\-\ widen\\:\\ 0\\.033425396063401454\ \(0\)\
\-\ saucer\\:\\ 0\\.033425396063401454\ \(0\)\
\-\ el\\-khoury\\:\\ 0\\.03175681537159831\ \(0\)\
\-\ years\\:\\ 0\\.03097831033356151\ \(0\)\
\-\ 5\\-8\\:\\ 0\\.029654652310832915\ \(0\)\
\-\ spondyloarthropathies\\:\\ 0\\.029654652310832915\ \(0\)\
\-\ 40\\:\\ 0\\.02958981562870925\ \(0\)\
\-\ gy\\:\\ 0\\.028269992900869075\ \(0\)\
\-\ ip\\:\\ 0\\.027720480997064454\ \(0\)\
\-\ rays\\:\\ 0\\.027720480997064454\ \(0\)\
\-\ bennett\\:\\ 0\\.02723577714662666\ \(0\)\
\-\ dl\\:\\ 0\\.02723577714662666\ \(0\)\
\-\ proliferative\\:\\ 0\\.0264099718155067\ \(0\)\
\-\ involvement\\:\\ 0\\.025777272894056104\ \(0\)\
\-\ rheumatology\\:\\ 0\\.025722506446522474\ \(0\)\
\-\ clinics\\:\\ 0\\.025722506446522474\ \(0\)\
\-\ america\\:\\ 0\\.02374895467589743\ \(0\)\
\-\ first\\:\\ 0\\.0236006867060564\ \(0\)\
\-\ begin\\:\\ 0\\.023374585218260698\ \(0\)\
\-\ north\\:\\ 0\\.023374585218260698\ \(0\)\
\-\ space\\:\\ 0\\.023263843679643084\ \(0\)\
\-\ ranges\\:\\ 0\\.02319944277209281\ \(0\)\
\-\ marginal\\:\\ 0\\.023031451025095875\ \(0\)\
\-\ mcp\\:\\ 0\\.022870048913353976\ \(0\)\
\-\ mean\\:\\ 0\\.021888933590535054\ \(0\)\
\-\ digits\\:\\ 0\\.021766081890330607\ \(0\)\
\-\ ankylosing\\:\\ 0\\.02130836322732557\ \(0\)\
\-\ proliferation\\:\\ 0\\.021201468221550834\ \(0\)\
\-\ spondylitis\\:\\ 0\\.020995664021655105\ \(0\)\
\-\ erosive\\:\\ 0\\.02089649714272893\ \(0\)\
\-\ away\\:\\ 0\\.020433624782948315\ \(0\)\
\-\ men\\:\\ 0\\.01986228138848652\ \(0\)\
\-\ progress\\:\\ 0\\.01986228138848652\ \(0\)\
\-\ strongly\\:\\ 0\\.01956821157786041\ \(0\)\
\-\ metatarsal\\:\\ 0\\.01936067720079501\ \(0\)\
\-\ percent\\:\\ 0\\.019163108397558956\ \(0\)\
\-\ k\\:\\ 0\\.019163108397558956\ \(0\)\
\-\ 59\\:\\ 0\\.018913624357162106\ \(0\)\
\-\ 2004\\:\\ 0\\.018913624357162106\ \(0\)\
\-\ articular\\:\\ 0\\.01885354699328905\ \(0\)\
\-\ radiologic\\:\\ 0\\.018296586713989618\ \(0\)\
\-\ hands\\:\\ 0\\.018193700696683374\ \(0\)\
\-\ feet\\:\\ 0\\.017995338137762065\ \(0\)\
\-\ 42\\:\\ 0\\.017806098988618763\ \(0\)\
\-\ extend\\:\\ 0\\.01762518078523968\ \(0\)\
\-\ bone\\:\\ 0\\.0174768286539907\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.017451882491617762\ \(0\)\
\-\ women\\:\\ 0\\.017086746213392724\ \(0\)\
\-\ asymmetric\\:\\ 0\\.017086746213392724\ \(0\)\
\-\ fourth\\:\\ 0\\.017009823855318018\ \(0\)\
\-\ lead\\:\\ 0\\.016860162768195075\ \(0\)\
\-\ margin\\:\\ 0\\.016542090034443447\ \(0\)\
\-\ 39\\:\\ 0\\.016342927314847357\ \(0\)\
\-\ diagnosis\\:\\ 0\\.016149953339756544\ \(0\)\
\-\ margins\\:\\ 0\\.015971376505497147\ \(0\)\
\-\ present\\:\\ 0\\.01588484571137186\ \(0\)\
\-\ few\\:\\ 0\\.015825947013952665\ \(0\)\
\-\ sclerotic\\:\\ 0\\.015741093980196554\ \(0\)\
\-\ surface\\:\\ 0\\.015523017724474288\ \(0\)\
\-\ deformity\\:\\ 0\\.015142880604593565\ \(0\)\
\-\ suggest\\:\\ 0\\.014976825890504811\ \(0\)\
\-\ characteristic\\:\\ 0\\.014884861698356679\ \(0\)\
\-\ formation\\:\\ 0\\.01451543783239491\ \(0\)\
\-\ occurs\\:\\ 0\\.014433130561997094\ \(0\)\
\-\ third\\:\\ 0\\.01410060367962962\ \(0\)\
\-\ partial\\:\\ 0\\.014063192273451628\ \(0\)\
\-\ \\:\\:\\ 0\\.013954010073958826\ \(0\)\
\-\ currently\\:\\ 0\\.013934867469185422\ \(0\)\
\-\ second\\:\\ 0\\.013506703437197442\ \(0\)\
\-\ skin\\:\\ 0\\.013506703437197442\ \(0\)\
\-\ n\\/a\\:\\ 0\\.01273747591505797\ \(0\)\
\-\ 20\\:\\ 0\\.012644095622045333\ \(0\)\
\-\ or\\:\\ 0\\.012364478382267993\ \(0\)\
\-\ inflammatory\\:\\ 0\\.012194715819720264\ \(0\)\
\-\ followed\\:\\ 0\\.011789612639418813\ \(0\)\
\-\ along\\:\\ 0\\.011621620892421879\ \(0\)\
\-\ severe\\:\\ 0\\.010820204938543227\ \(0\)\
\-\ age\\:\\ 0\\.010703334673021838\ \(0\)\
\-\ from\\:\\ 0\\.010423339202915329\ \(0\)\
\-\ in\\:\\ 0\\.010404869880006294\ \(0\)\
\-\ loss\\:\\ 0\\.01020767149163967\ \(0\)\
\-\ appearance\\:\\ 0\\.010057228710842147\ \(0\)\
\-\ \\,\\:\\ 0\\.010026298722862495\ \(0\)\
\-\ chronic\\:\\ 0\\.009905307131304527\ \(0\)\
\-\ are\\:\\ 0\\.009587439280079027\ \(0\)\
\-\ patients\\:\\ 0\\.009101130038543317\ \(0\)\
\-\ and\\:\\ 0\\.00888933361640585\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.008642531019060977\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.008476335399103882\ \(0\)\
\-\ demonstrate\\:\\ 0\\.008092395643345848\ \(0\)\
\-\ can\\:\\ 0\\.007976223672712222\ \(0\)\
\-\ the\\:\\ 0\\.007964979365640992\ \(0\)\
\-\ left\\:\\ 0\\.007869179170970492\ \(0\)\
\-\ may\\:\\ 0\\.00771328546871656\ \(0\)\
\-\ lateral\\:\\ 0\\.007599456977878808\ \(0\)\
\-\ right\\:\\ 0\\.007420837112019891\ \(0\)\
\-\ is\\:\\ 0\\.0069418614615398225\ \(0\)\
\-\ of\\:\\ 0\\.006232713622937653\ \(0\)\
\-\ by\\:\\ 0\\.00585543581582253\ \(0\)\
\-\ disease\\:\\ 0\\.00574789111611401\ \(0\)\
\-\ to\\:\\ 0\\.005272445783246743\ \(0\)\
\-\ a\\:\\ 0\\.004896293849612361\ \(0\)\
\-\ history\\:\\ 0\\.004856849949411866\ \(0\)\
\-\ \\(\\:\\ 0\\.0029726820010035414\ \(0\)\
\-\ \\)\\:\\ 0\\.0029363691033469346\ \(0\)\
\-\ \\.\\:\\ 0\\.0024835066405550893\ \(0\)\
\-\ with\\:\\ 0\\.0019259946681463333\ \(0\)\
